Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 11641 - 11648 of 12011 results
Arizona Hospital Workers Fired for Inappropriately Accessing Shooting Victim Records
January 13, 2011| Blog| Viewpoint
Comparison of Commerce Department and Federal Trade Commission Privacy Proposals
January 7, 2011| Blog| Viewpoint
Commerce Department Seeking Public Input on Proposed Privacy Framework
December 22, 2010| Blog| Viewpoint
Data Breach at NYC "Hop-on, Hop-off" Tour Company -- 110,000 credit card numbers stolen
December 22, 2010| Blog| Viewpoint
It's almost 2011. Do you know where your Red Flags Rule compliance program is?
December 7, 2010| Blog| Viewpoint
Questions Asked by the FTC in the Privacy Report - Part II
December 7, 2010| Blog| Viewpoint
FTC to Industry on Consumer Privacy: You "Must Do Better" - UPDATE
December 1, 2010| Blog| Viewpoint
EchoMetrix Settles FTC Complaint Over Disclosure of Children's Information to Marketers
November 30, 2010| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|